1. Home
  2. Live Updates
  3. Janssen pharmaceutical companies

Live Breaking News & Updates on Janssen pharmaceutical companies

Stay informed with the latest breaking news from Janssen pharmaceutical companies on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Janssen pharmaceutical companies and stay connected to the pulse of your community

MustGrow Biologics : Year End 2023 - MarketScreener

MUSTGROW BIOLOGICS CORP.


Annual Information Form


For the year ended December 31, 2023


April 23, 2024



...

Chile , Oregon , United-states , United-kingdom , Prince-edward-island , Canada , Mexico , Saskatoon , Saskatchewan , Quebec , Peru , Washington

FDA Oncologic Drugs Advisory Committee Votes in Favor of Cilta-Cel as Early Treatment for Multiple Myeloma

The FDA’s ODAC sought to determine whether cilta-cel has a favorable benefit-risk profile for patients with multiple myeloma. The FDA’s ODAC unanimously voted that the potential benefits of cilta-cel outweigh its risks for its proposed indication in patients with multiple myeloma.

United-states , Ravi-madan , Mary-kwok , Susan-lattimore , Irene-ghobrial , Helkha-peredo-pinto , Janssen-pharmaceutical-companies-of-johnson , Drug-administration , Oncologic-drugs-advisory-committee , Dana-farber-cancer-institute , University-of-washington-school-medicine , Janssen-biotech-inc

Zura Bio Announces Robert Lisicki as CEO and Director

- Succeeds Founding CEO, Dr. Someit Sidhu, who will continue as a Board Director


- Recognized as inspirational industry leader with exceptional R&D, commercial and global executive experience


-...

New-york , United-states , Robert-lisicki , Amit-munshi , Someit-sidhu , Zura-bio , Pfizer , Zura-bio-limited-nasdaq , Amgen , Daiichi-sankyo-inc , Janssen-pharmaceutical-companies-of-johnson , University-of-new-york

Navigating Paxlovid Interactions With Anticoagulants

Interactions between nirmatrelvir/ritonavir and direct oral anticoagulants is complicated, and a point of contrasting views between the US and EU medical communities.

Germany , United-states , New-jersey , Washington , J-clin-pharmacol , Dabigatran-pradaxa , Apixaban-eliquis , Pradaxa-dabigatran-etexilate , Evan-shockey , Bristol-myers-squibb , National-institutes-of-health , University-of-maryland-school-pharmacy

Johnson & Johnson Expands IP Policy to Create Broad Access in 128 Countries for Development of New and Optimized HIV Medicine Formulations for Children Living with HIV

Johnson & Johnson Expands IP Policy to Create Broad Access in 128 Countries for Development of New and Optimized HIV Medicine Formulations for Children Living with HIV
dominicanrepublicpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dominicanrepublicpost.com Daily Mail and Mail on Sunday newspapers.

Algeria , Ukraine , Dominican-republic , American-samoa , Tonga , Guatemala , Barbados , South-korea , Turkey , Jamaica , Tunisia , Iraq

Psoriasis: What is it, symptoms and treatment

Psoriasis: What is it, symptoms and treatment
iol.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iol.co.za Daily Mail and Mail on Sunday newspapers.

South-africa , Norway , United-states , American , Ahmed-el-hofy , El-hofy , Janssen-pharmaceutical-companies-of-johnson , Janssen-pharmaceutical-companies , Native-american , East-asia , South-asian ,

NICE recommends first licenced treatment for AL amyloidosis

Eligible individuals in England and Wales can access the first licensed treatment for amyloid light-chain amyloidosis on the NHS. The ...

United-kingdom , Northern-ireland , Craigavon , Scotland , Amanda-cunnington , Sophie-castell , National-institute-for-health , Janssen-biotech-inc , Russell-publishing , Janssen-pharmaceutical-companies , Johnson , Care-excellence

NICE recommends first licenced treatment for AL amyloidosis

NICE recommends first licenced treatment for AL amyloidosis
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Northern-ireland , Craigavon , United-kingdom , Scotland , Sophie-castell , Amanda-cunnington , Janssen-pharmaceutical-companies-of-johnson , National-institute-for-health , Janssen-biotech-inc , National-institute , Care-excellence , Janssen-pharmaceutical-companies

Foundational V3 Framework Extended to Incorporate Usability Validation of Sensor-Based Digital Health Technologies

Digital Medicine Academy® supports the extension launch with new V3+ Crash Course

Boston , Massachusetts , United-states , Jennifer-goldsack , Thomas-switzer , Digital-medicine-society , Stel-life-inc , Genentech , Principal-digital-health-scientist , Digital-health-measurement-collaborative-community-datacc , Digital-medicine-society-dime , Digital-medicine-academy

CHMP meeting highlights: February 2024

CHMP meeting highlights: February 2024
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Edmond-chan , Johnson-company , Janssen-pharmaceutical-companies-of-johnson , Committee-for-medicinal-products-human-use , Medicinal-products , Human-use , Marketing-authorisation-application , Apremilast-accord , Nintedanib-accord , Janssen-pharmaceutical-companies , Senior-director , Area-lead-haematology